Tags

Type your tag names separated by a space and hit enter

Comparison of Dexamethasone-Dimenhydrinate and Dexamethasone-Ondansetron in Prevention of Nausea and Vomiting in Postoperative Patients.
Aesthetic Plast Surg. 2017 Feb; 41(1):204-210.AP

Abstract

INTRODUCTION

Postoperative Nausea and Vomiting is one of the most common problems after implementation of general anesthesia. The incidence can reach 80% in high-risk patients, depending on the type of surgery. In our study, we aimed to compare dexamethasone-dimenhydrinate and dexamethasone-ondansetron combinations in prevention of nausea and vomiting in postoperative patients.

METHOD

Sixty 18-65-year-olds ASAI-II females who underwent rhinoplasty were included in the study. Patients were randomly included in two groups: Dexamethasone-dimenhydrinate group (group DD) and dexamethasone-ondansetron group (group DO). All patients received dexamethasone 8 mg iv after endotracheal intubation. Anesthesia continuation was established with sevoflurane, air-oxygen mixture and remifentanil infusion. At the 30th minute of the operation, group DO received ondansetron 4 mg iv and group DD received dimenhydrinate 1 mg/kg iv. For postoperative analgesia tramadol (1.5 mg/kg) iv, tenoksikam (20 mg) and afterward for postoperative patient-controlled tramadol was used. In the postoperative recovery room, nausea and vomiting were evaluated at the 30th, 60th, 120th minutes and at the end of 24 h. Total amount of tramadol was recorded. All results were statistically evaluated.

OBSERVATIONS

Demographics and Apfel risk scores of both groups were similar. Surgical operation duration (p = 0.038) and total preoperative remifentanil consumption were higher in group DD (p = 0.006). In group DO, nausea at 30 and 60 min (p = 0.001, p = 0.007), retching at 30 and 60 min (p = 0.002, p = 0.006) were higher than group DD. The additional antiemetic need in group DO was significantly higher at 30 min (p = 0.001). Postoperative analgesic consumption was similar in both groups.

RESULT

Our study revealed that dexamethasone-dimenhydrinate combination was more effective than dexamethasone-ondansetron in prevention of nausea and vomiting after rhinoplasty operations.

LEVEL OF EVIDENCE IV

This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .

Authors+Show Affiliations

Department of Anesthesiology and Reanimation, Yeditepe University School of Medicine, Istanbul, Turkey. nurcankizilcik@gmail.com.Department of Anesthesiology and Reanimation, Yeditepe University School of Medicine, Istanbul, Turkey.Department of Anesthesiology and Reanimation, Yeditepe University School of Medicine, Istanbul, Turkey.Department of Anesthesiology and Reanimation, Yeditepe University School of Medicine, Istanbul, Turkey.Department of Aesthetic and Plastic Surgery, Yeditepe University School of Medicine, Istanbul, Turkey.Department of Biostatistics, Yeditepe University School of Medicine, Istanbul, Turkey.Department of Anesthesiology and Reanimation, Yeditepe University School of Medicine, Istanbul, Turkey.

Pub Type(s)

Comparative Study
Journal Article
Randomized Controlled Trial

Language

eng

PubMed ID

28039501

Citation

Kizilcik, Nurcan, et al. "Comparison of Dexamethasone-Dimenhydrinate and Dexamethasone-Ondansetron in Prevention of Nausea and Vomiting in Postoperative Patients." Aesthetic Plastic Surgery, vol. 41, no. 1, 2017, pp. 204-210.
Kizilcik N, Bilgen S, Menda F, et al. Comparison of Dexamethasone-Dimenhydrinate and Dexamethasone-Ondansetron in Prevention of Nausea and Vomiting in Postoperative Patients. Aesthetic Plast Surg. 2017;41(1):204-210.
Kizilcik, N., Bilgen, S., Menda, F., Türe, H., Aydın, B., Kaspar, E. C., & Koner, O. (2017). Comparison of Dexamethasone-Dimenhydrinate and Dexamethasone-Ondansetron in Prevention of Nausea and Vomiting in Postoperative Patients. Aesthetic Plastic Surgery, 41(1), 204-210. https://doi.org/10.1007/s00266-016-0772-0
Kizilcik N, et al. Comparison of Dexamethasone-Dimenhydrinate and Dexamethasone-Ondansetron in Prevention of Nausea and Vomiting in Postoperative Patients. Aesthetic Plast Surg. 2017;41(1):204-210. PubMed PMID: 28039501.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Comparison of Dexamethasone-Dimenhydrinate and Dexamethasone-Ondansetron in Prevention of Nausea and Vomiting in Postoperative Patients. AU - Kizilcik,Nurcan, AU - Bilgen,Sevgi, AU - Menda,Ferdi, AU - Türe,Hatice, AU - Aydın,Bilgehan, AU - Kaspar,Elif Cigdem, AU - Koner,Ozge, Y1 - 2016/12/30/ PY - 2016/05/03/received PY - 2016/10/31/accepted PY - 2017/1/1/pubmed PY - 2017/11/29/medline PY - 2017/1/1/entrez KW - Nausea KW - Rhinoplasty KW - Vomiting SP - 204 EP - 210 JF - Aesthetic plastic surgery JO - Aesthetic Plast Surg VL - 41 IS - 1 N2 - INTRODUCTION: Postoperative Nausea and Vomiting is one of the most common problems after implementation of general anesthesia. The incidence can reach 80% in high-risk patients, depending on the type of surgery. In our study, we aimed to compare dexamethasone-dimenhydrinate and dexamethasone-ondansetron combinations in prevention of nausea and vomiting in postoperative patients. METHOD: Sixty 18-65-year-olds ASAI-II females who underwent rhinoplasty were included in the study. Patients were randomly included in two groups: Dexamethasone-dimenhydrinate group (group DD) and dexamethasone-ondansetron group (group DO). All patients received dexamethasone 8 mg iv after endotracheal intubation. Anesthesia continuation was established with sevoflurane, air-oxygen mixture and remifentanil infusion. At the 30th minute of the operation, group DO received ondansetron 4 mg iv and group DD received dimenhydrinate 1 mg/kg iv. For postoperative analgesia tramadol (1.5 mg/kg) iv, tenoksikam (20 mg) and afterward for postoperative patient-controlled tramadol was used. In the postoperative recovery room, nausea and vomiting were evaluated at the 30th, 60th, 120th minutes and at the end of 24 h. Total amount of tramadol was recorded. All results were statistically evaluated. OBSERVATIONS: Demographics and Apfel risk scores of both groups were similar. Surgical operation duration (p = 0.038) and total preoperative remifentanil consumption were higher in group DD (p = 0.006). In group DO, nausea at 30 and 60 min (p = 0.001, p = 0.007), retching at 30 and 60 min (p = 0.002, p = 0.006) were higher than group DD. The additional antiemetic need in group DO was significantly higher at 30 min (p = 0.001). Postoperative analgesic consumption was similar in both groups. RESULT: Our study revealed that dexamethasone-dimenhydrinate combination was more effective than dexamethasone-ondansetron in prevention of nausea and vomiting after rhinoplasty operations. LEVEL OF EVIDENCE IV: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 . SN - 1432-5241 UR - https://www.unboundmedicine.com/medline/citation/28039501/Comparison_of_Dexamethasone_Dimenhydrinate_and_Dexamethasone_Ondansetron_in_Prevention_of_Nausea_and_Vomiting_in_Postoperative_Patients_ L2 - https://dx.doi.org/10.1007/s00266-016-0772-0 DB - PRIME DP - Unbound Medicine ER -